FDA proposes tougher rules for tattoo providers to curb contaminated inks
Regulators want your next tattoo to be as safe as it is trendy.
Jun 15, 2023
0
7
Regulators want your next tattoo to be as safe as it is trendy.
Jun 15, 2023
0
7
The European Alliance of Associations for Rheumatology, EULAR, wishes to highlight increasing shortages of vital anti-inflammatory drugs used in the treatment of arthritis, vasculitis and other inflammatory RMDs.
Sep 16, 2021
0
25
(HealthDay)—The U.S. Food and Drug Administration is investigating the possible association between a rare brain infection and the multiple sclerosis (MS) drug Gilenya (fingolimod), according to a drug safety alert issued ...
Aug 31, 2013
0
0
A Colorado School of Public Health researcher has found that laws designed to illuminate financial links between doctors and pharmaceutical companies have little or no effect on what drugs physicians prescribe.
May 29, 2012
0
0
Breast-cancer researchers at the University of Wisconsin-Madison have found that two related receptors in a robust signaling pathway must work together as a team to maintain normal activity in mammary stem cells.
May 30, 2012
0
0
British pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant in Singapore to manufacture next-generation drugs to treat cancer.
May 20, 2024
0
0
Outlining a daunting timeline for development of any updated COVID-19 vaccine for next fall, federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin ...
Apr 8, 2022
0
2
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Apr 16, 2013
1
0
The National Institute for Health and Care Excellence (NICE) says it cannot give a positive decision over whether to recommend a new drug for ovarian cancer unless its makers provide more information on cost. A final decision ...
Aug 7, 2015
0
10
For more than 30 years, section 340B of the Public Health Service Act has required drug manufacturers to sell outpatient drugs at discounted prices to certain safety-net hospitals and health care organizations that serve ...
Oct 27, 2023
0
0